News and Media

Latest News Release

Transaction creates increased clinical and economic value for 11,500 specialty providers, including more than 7,000 physicians across 1,200 independent physician practices Transaction creates...


Press Releases

Cardinal Health Sets the Standard in Non-Latex Protection with Launch of New Glove
DUBLIN, Ohio, August 10, 2006 - Cardinal Health, Inc. (NYSE: CAH), the leading provider of products and services supporting the health-care industry, introduced today its Esteem® Blue Surgical Glove with Neu-Thera™ a synthetic glove designed for use as an underglove when double gloving. Earlier this year, the company launched a latex version of the glove called Protegrity Blue with Neu-Thera™.
“As a leader in glove technology, we know there is demand for surgical gloves that meet customers’ high standards for double gloving which include superior comfort, enhanced tactile sensitivity and effortless outer glove donnability,” said LeeAnn Schuette, director of marketing for the gloves group of Cardinal Health. “This new under glove also offers our Neu-Thera emollient coating, which is clinically proven to improve the health of clinicians’ skin. Customers have been asking for a high-quality synthetic glove they can use when double-gloving. We are pleased this new glove will meet their needs.”
For the first time, in its new Recommended Practices for nurses, AORN, the professional organization of perioperative registered nurses, is recommending that health-care personnel double glove for invasive procedures. AORN cites numerous studies that demonstrate the reduced risk of blood exposure associated with double gloving, as well as the recommendations of the Centers for Disease Control and Prevention, The American College of Surgeons and the American Academy of Orthopedic Surgeons.
Esteem Blue with Neu-Thera™ is made from a unique polyisoprene formulation that is structurally similar to Natural Rubber Latex. It has the fit and feel of latex, without any of the proteins associated with allergic reactions.
Up until now, polyisoprene was in short supply with polyisoprene gloves being sold on a limited basis. Polyisoprene manufacturers have greatly expanded their investments in manufacturing, making the new glove widely available.
Cardinal Health invests in research and technological innovations to meet the needs of health-care providers and their patients. For more than 40 years, the company has been offering the most extensive, highest quality and technologically-advanced lines of medical gloves. In addition to the Esteem polyisoprene surgical gloves, the company also offers the Protegrity brand of latex powder-free surgical gloves, made with an advanced triple-dip bonding technology. Cardinal Health also offers a complete line of latex and synthetic examination gloves to meet the needs of health-care professionals in the lab, physician's office, hospital and other healthcare settings.

About Cardinal Health

Headquartered in Dublin, Ohio, Cardinal Health, Inc. (NYSE: CAH) is an $81 billion, global company serving the health-care industry with a broad portfolio of products and services. Through its diverse offering, Cardinal Health delivers health-care solutions that help customers reduce their costs, improve safety and productivity, and deliver better care to patients.  The company manufacturers, packages and distributes pharmaceuticals and medical supplies, offers a range of clinical services and develops automation products that improve the management and delivery of supplies and medication for hospitals, physician offices and pharmacies. Ranked No. 19 on the Fortune 500, Cardinal Health employs more than 55,000 people on six continents.
More information about the company may be found at

More Company News

Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved a quarterly dividend of $0.5006 per share out of the Company's capital surplus. The dividend will be payable on...


Cardinal Health (NYSE: CAH) today released its Fiscal 2023 Environmental, Social and Governance (ESG) Report, highlighting the company's work toward building a healthier, more equitable future....


Revenue increased 12% to $57.4 billion GAAP1 operating earnings were $482 million; GAAP diluted EPS was $1.43 Non-GAAP operating earnings increased 20% to $562 million; non-GAAP diluted EPS...


Transaction creates increased clinical and economic value for 11,500 specialty providers, including more than 7,000 physicians across 1,200 independent physician practices Transaction creates...

View all company news »